Humacyte (HUMA) Long-Term Debt Repayments (2020 - 2026)
Humacyte (HUMA) recorded Long-Term Debt Repayments of $174,000 in Q2 2026, down 76.1% from $727,000 a year earlier.
Analysis
Humacyte (HUMA) Long-Term Debt Repayments (2020 - 2026) Analysis & Trends
On a TTM basis, Humacyte's Long-Term Debt Repayments came in at $86.76 million as of Jun 30, 2026; for FY2025, it was $88 million.
- Annual Long-Term Debt Repayments has a five-year compound annual growth rate of 125.8% (FY2020 to FY2025).
- Across earlier years, Long-Term Debt Repayments came in at $2.58 million in FY2024 (-91.8%), $31.5 million in FY2023, $1.98 million in FY2022 (+14.6%) and $1.73 million in FY2021 (+15.3%).
- The Q2 2026 figure is the lowest quarterly Long-Term Debt Repayments in data going back to Q4 2020.
- Peak year-over-year performance for Long-Term Debt Repayments in the last five years was growth of 15.0% in Q4 2021, against a decline of 97.9% in Q2 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.00 Mn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 2.00 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 5.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -2.45 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 17.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | Humacyte | 147.23 Mn | 147.23 Mn | -825,000.00 | 174,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 174,000.00 |
| Dec 31, 2025 | 38.00 Mn |
| Sep 30, 2025 | 48.59 Mn |
| Jun 30, 2025 | 727,000.00 |
| Mar 31, 2025 | 687,000.00 |
| Dec 31, 2024 | 673,000.00 |
| Sep 30, 2024 | 659,000.00 |
| Jun 30, 2024 | 644,000.00 |
| Mar 31, 2024 | 603,000.00 |
| Jun 30, 2023 | 30.97 Mn |
| Mar 31, 2023 | 528,000.00 |
| Dec 31, 2022 | 518,000.00 |
| Sep 30, 2022 | 506,000.00 |
| Jun 30, 2022 | 495,000.00 |
| Mar 31, 2022 | 462,000.00 |
| Dec 31, 2021 | 452,000.00 |
| Sep 30, 2021 | 443,000.00 |
| Jun 30, 2021 | 432,000.00 |
| Mar 31, 2021 | 402,000.00 |
| Dec 31, 2020 | 393,000.00 |
API Access
Humacyte Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=HUMA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "HUMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=HUMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();